# Fondaparinux Sodium

NDC: 55111-681
Generic name: Fondaparinux Sodium
Labeler / Manufacturer: Dr. Reddy's Laboratories Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20110714

FDA application: ANDA091316

## Active ingredients

- FONDAPARINUX SODIUM: 10 mg/.8mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55111-681"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55111-681
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=49e0d7bc-3f49-849b-c77c-98682d1c0d19